9.99澳幣0.11(1.09%)
2024/04/18更新
績效 / 1月5.17%
3月2.66%
1年2.37%
晨星評等-
- 1.現金6.19%
- 2.股票34.41%
- 3.債券0.00%
- 4.其他59.40%
- 1.美國57.32%
- 2.歐洲不包含歐元區22.49%
- 3.歐元區5.07%
- 4.英國3.15%
- 1.Eli Lilly and Co8.89%
- 2.Novo Nordisk A/S Class B8.42%
- 3.Thermo Fisher Scientific Inc7.38%
- 4.AbbVie Inc7.17%
- 5.Veeva Systems Inc Class A6.77%
- 6.Edwards Lifesciences Corp6.07%
- 7.Vertex Pharmaceuticals Inc5.31%
- 8.Sartorius Stedim Biotech SA5.07%
- 9.Alcon Inc4.74%
- 10.Viking Therapeutics Inc4.17%
- 1.現金6.19%
- 2.股票34.41%
- 3.債券0.00%
- 4.其他59.40%
- 1.美國57.32%
- 2.歐洲不包含歐元區22.49%
- 3.歐元區5.07%
- 4.英國3.15%
- 1.Eli Lilly and Co8.89%
- 2.Novo Nordisk A/S Class B8.42%
- 3.Thermo Fisher Scientific Inc7.38%
- 4.AbbVie Inc7.17%
- 5.Veeva Systems Inc Class A6.77%
- 6.Edwards Lifesciences Corp6.07%
- 7.Vertex Pharmaceuticals Inc5.31%
- 8.Sartorius Stedim Biotech SA5.07%
- 9.Alcon Inc4.74%
- 10.Viking Therapeutics Inc4.17%